US Stock MarketDetailed Quotes

TTOO T2 Biosystems

Watchlist

5.3400
-0.0900-1.66%

Close Jun 28 16:00 ET

5.3400
0.00000.00%

Post 19:13 ET

91.13MMarket Cap0.05P/E (TTM)

T2 Biosystems Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

9.71%-11.68M

4.92%-48.14M

8.84%-9.42M

15.78%-13.39M

-24.42%-12.39M

10.39%-12.94M

-30.24%-50.63M

-4.95%-10.33M

-63.49%-15.9M

6.05%-9.96M

Net income from continuing operations

24.66%-13.53M

19.23%-50.08M

-2.39%-10.34M

11.22%-15.43M

64.81%-6.35M

-8.91%-17.97M

-25.92%-62M

16.84%-10.1M

-24.44%-17.38M

-44.56%-18.03M

Operating gains losses

-97.10%80K

-671.77%-4.74M

96.48%-31K

2,160.61%746K

---8.21M

--2.76M

180.96%829K

---881K

--33K

----

Depreciation and amortization

-75.00%64K

-17.96%859K

-70.98%74K

0.77%262K

8.54%267K

-10.49%256K

-58.75%1.05M

-54.14%255K

-55.48%260K

-58.09%246K

Other non cash items

-16.77%705K

-10.57%3M

-19.24%676K

-28.31%623K

5.16%856K

1.19%847K

-14.67%3.36M

-17.70%837K

-12.40%869K

-16.26%814K

Change In working capital

11.49%-593K

-703.58%-4.04M

67.85%-523K

-181.26%-2.99M

-96.38%138K

58.67%-670K

76.83%-503K

-118.68%-1.63M

-650.26%-1.06M

386.03%3.81M

-Change in receivables

-120.00%-168K

-74.99%743K

51.97%-281K

-81.63%210K

-101.59%-26K

8.67%840K

8,588.57%2.97M

35.86%-585K

570.37%1.14M

2,881.82%1.64M

-Change in inventory

115.70%149K

21.60%-744K

-52.99%-205K

-115.46%-165K

265.23%575K

38.14%-949K

51.08%-949K

-436.00%-134K

1,146.08%1.07M

10.08%-348K

-Change in prepaid assets

13.04%156K

-216.77%-550K

-161.74%-71K

-196.62%-1.05M

-80.06%436K

109.35%138K

200.86%471K

-48.89%115K

67.79%-355K

399.32%2.19M

-Change in payables and accrued expense

16.14%-317K

-70.27%-2.22M

169.22%398K

36.62%-1.62M

-180.10%-620K

-135.83%-378K

-185.29%-1.31M

-248.20%-575K

-386.88%-2.56M

235.79%774K

-Change in other current liabilities

-19.69%-383K

1.24%-1.35M

29.14%-355K

-15.05%-344K

-14.43%-333K

-15.11%-320K

-18.94%-1.37M

-65.35%-501K

-144.69%-299K

62.21%-291K

-Change in other working capital

-2,900.00%-30K

125.78%83K

-116.98%-9K

77.97%-13K

168.39%106K

99.38%-1K

-198.15%-322K

145.30%53K

-174.68%-59K

-59.79%-155K

Cash from discontinued investing activities

Operating cash flow

9.71%-11.68M

4.92%-48.14M

8.84%-9.42M

15.78%-13.39M

-24.42%-12.39M

10.39%-12.94M

-30.24%-50.63M

-4.95%-10.33M

-63.49%-15.9M

6.05%-9.96M

Investing cash flow

Cash flow from continuing investing activities

-101.99%-192K

27.78%-26K

89.68%-13K

-100.34%-33K

-313.79%-120K

-61.04%9.66M

-100.37%-36K

-400.00%-126K

-20.53%9.85M

Net PPE purchase and sale

--0

43.36%-192K

27.78%-26K

89.68%-13K

77.70%-33K

-313.79%-120K

26.30%-339K

81.91%-36K

-400.00%-126K

-39.62%-148K

Net investment purchase and sale

----

--0

----

-60.41%10M

--0

----

Cash from discontinued investing activities

Investing cash flow

--0

-101.99%-192K

27.78%-26K

89.68%-13K

-100.34%-33K

-313.79%-120K

-61.04%9.66M

-100.37%-36K

-400.00%-126K

-20.53%9.85M

Financing cash flow

Cash flow from continuing financing activities

-81.41%2.2M

81.35%52.69M

8.56%812K

-6.65%21.64M

368.94%18.39M

885.69%11.85M

41.49%29.05M

212.97%748K

96,495.83%23.18M

-80.61%3.92M

Net common stock issuance

-81.41%2.2M

80.82%52.73M

-24.43%795K

-5.16%21.7M

384.58%18.39M

727.37%11.85M

46.04%29.16M

--1.05M

--22.88M

-81.00%3.79M

Net preferred stock issuance

----

--0

----

---30K

---330K

----

Proceeds from stock option exercised by employees

----

-88.48%19K

-34.62%17K

--0

----

-70.90%165K

-89.12%26K

--0

----

Net other financing activities

---1K

74.49%-62K

--0

----

---243K

--0

---1K

---12K

Cash from discontinued financing activities

Financing cash flow

-81.41%2.2M

81.35%52.69M

8.56%812K

-6.65%21.64M

368.94%18.39M

885.69%11.85M

41.49%29.05M

212.97%748K

96,495.83%23.18M

-80.61%3.92M

Net cash flow

Beginning cash position

36.70%16.24M

-50.08%11.88M

15.69%24.87M

15.98%16.64M

1.33%10.67M

-50.08%11.88M

37.20%23.8M

-8.90%21.5M

-56.87%14.34M

-6.35%10.53M

Current changes in cash

-682.26%-9.48M

136.59%4.36M

10.26%-8.63M

15.11%8.24M

56.41%5.97M

90.87%-1.21M

-284.69%-11.92M

-4,957.07%-9.62M

174.05%7.15M

-82.67%3.82M

End cash Position

-36.64%6.76M

36.70%16.24M

15.69%24.87M

15.98%16.64M

1.33%10.67M

-50.08%11.88M

-8.90%21.5M

-56.87%14.34M

Free cash flow

10.54%-11.68M

5.18%-48.33M

8.90%-9.44M

16.36%-13.41M

-22.92%-12.42M

9.74%-13.06M

-29.58%-50.97M

-3.23%-10.37M

-65.50%-16.03M

5.60%-10.1M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	9.71%-11.68M	4.92%-48.14M	8.84%-9.42M	15.78%-13.39M	-24.42%-12.39M	10.39%-12.94M	-30.24%-50.63M	-4.95%-10.33M	-63.49%-15.9M	6.05%-9.96M
Net income from continuing operations	24.66%-13.53M	19.23%-50.08M	-2.39%-10.34M	11.22%-15.43M	64.81%-6.35M	-8.91%-17.97M	-25.92%-62M	16.84%-10.1M	-24.44%-17.38M	-44.56%-18.03M
Operating gains losses	-97.10%80K	-671.77%-4.74M	96.48%-31K	2,160.61%746K	---8.21M	--2.76M	180.96%829K	---881K	--33K	----
Depreciation and amortization	-75.00%64K	-17.96%859K	-70.98%74K	0.77%262K	8.54%267K	-10.49%256K	-58.75%1.05M	-54.14%255K	-55.48%260K	-58.09%246K
Other non cash items	-16.77%705K	-10.57%3M	-19.24%676K	-28.31%623K	5.16%856K	1.19%847K	-14.67%3.36M	-17.70%837K	-12.40%869K	-16.26%814K
Change In working capital	11.49%-593K	-703.58%-4.04M	67.85%-523K	-181.26%-2.99M	-96.38%138K	58.67%-670K	76.83%-503K	-118.68%-1.63M	-650.26%-1.06M	386.03%3.81M
-Change in receivables	-120.00%-168K	-74.99%743K	51.97%-281K	-81.63%210K	-101.59%-26K	8.67%840K	8,588.57%2.97M	35.86%-585K	570.37%1.14M	2,881.82%1.64M
-Change in inventory	115.70%149K	21.60%-744K	-52.99%-205K	-115.46%-165K	265.23%575K	38.14%-949K	51.08%-949K	-436.00%-134K	1,146.08%1.07M	10.08%-348K
-Change in prepaid assets	13.04%156K	-216.77%-550K	-161.74%-71K	-196.62%-1.05M	-80.06%436K	109.35%138K	200.86%471K	-48.89%115K	67.79%-355K	399.32%2.19M
-Change in payables and accrued expense	16.14%-317K	-70.27%-2.22M	169.22%398K	36.62%-1.62M	-180.10%-620K	-135.83%-378K	-185.29%-1.31M	-248.20%-575K	-386.88%-2.56M	235.79%774K
-Change in other current liabilities	-19.69%-383K	1.24%-1.35M	29.14%-355K	-15.05%-344K	-14.43%-333K	-15.11%-320K	-18.94%-1.37M	-65.35%-501K	-144.69%-299K	62.21%-291K
-Change in other working capital	-2,900.00%-30K	125.78%83K	-116.98%-9K	77.97%-13K	168.39%106K	99.38%-1K	-198.15%-322K	145.30%53K	-174.68%-59K	-59.79%-155K
Cash from discontinued investing activities
Operating cash flow	9.71%-11.68M	4.92%-48.14M	8.84%-9.42M	15.78%-13.39M	-24.42%-12.39M	10.39%-12.94M	-30.24%-50.63M	-4.95%-10.33M	-63.49%-15.9M	6.05%-9.96M
Investing cash flow
Cash flow from continuing investing activities	0	-101.99%-192K	27.78%-26K	89.68%-13K	-100.34%-33K	-313.79%-120K	-61.04%9.66M	-100.37%-36K	-400.00%-126K	-20.53%9.85M
Net PPE purchase and sale	--0	43.36%-192K	27.78%-26K	89.68%-13K	77.70%-33K	-313.79%-120K	26.30%-339K	81.91%-36K	-400.00%-126K	-39.62%-148K
Net investment purchase and sale	----	--0	--0	--0	----	----	-60.41%10M	--0	--0	----
Cash from discontinued investing activities
Investing cash flow	--0	-101.99%-192K	27.78%-26K	89.68%-13K	-100.34%-33K	-313.79%-120K	-61.04%9.66M	-100.37%-36K	-400.00%-126K	-20.53%9.85M
Financing cash flow
Cash flow from continuing financing activities	-81.41%2.2M	81.35%52.69M	8.56%812K	-6.65%21.64M	368.94%18.39M	885.69%11.85M	41.49%29.05M	212.97%748K	96,495.83%23.18M	-80.61%3.92M
Net common stock issuance	-81.41%2.2M	80.82%52.73M	-24.43%795K	-5.16%21.7M	384.58%18.39M	727.37%11.85M	46.04%29.16M	--1.05M	--22.88M	-81.00%3.79M
Net preferred stock issuance	----	--0	--0	----	----	----	---30K	---330K	----	----
Proceeds from stock option exercised by employees	----	-88.48%19K	-34.62%17K	--0	----	----	-70.90%165K	-89.12%26K	--0	----
Net other financing activities	---1K	74.49%-62K	--0	----	----	----	---243K	--0	---1K	---12K
Cash from discontinued financing activities
Financing cash flow	-81.41%2.2M	81.35%52.69M	8.56%812K	-6.65%21.64M	368.94%18.39M	885.69%11.85M	41.49%29.05M	212.97%748K	96,495.83%23.18M	-80.61%3.92M
Net cash flow
Beginning cash position	36.70%16.24M	-50.08%11.88M	15.69%24.87M	15.98%16.64M	1.33%10.67M	-50.08%11.88M	37.20%23.8M	-8.90%21.5M	-56.87%14.34M	-6.35%10.53M
Current changes in cash	-682.26%-9.48M	136.59%4.36M	10.26%-8.63M	15.11%8.24M	56.41%5.97M	90.87%-1.21M	-284.69%-11.92M	-4,957.07%-9.62M	174.05%7.15M	-82.67%3.82M
End cash Position	-36.64%6.76M	36.70%16.24M	36.70%16.24M	15.69%24.87M	15.98%16.64M	1.33%10.67M	-50.08%11.88M	-50.08%11.88M	-8.90%21.5M	-56.87%14.34M
Free cash flow	10.54%-11.68M	5.18%-48.33M	8.90%-9.44M	16.36%-13.41M	-22.92%-12.42M	9.74%-13.06M	-29.58%-50.97M	-3.23%-10.37M	-65.50%-16.03M	5.60%-10.1M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall